Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: findings from the Dutch Diabetes Pearl cohort.
de Jong M, Oskam MJ, Sep SJS, Ozcan B, Rutters F, Sijbrands EJG, Elders PJM, Siegelaar SE, DeVries JH, Tack CJ, Schroijen M, de Valk HW, Abbink EJ, Stehouwer CDA, Jazet I, Wolffenbuttel BHR, Peters SAE, Schram MT; Diabetes Pearl from the Parelsnoer Initiative. de Jong M, et al. Among authors: devries jh. BMJ Open Diabetes Res Care. 2020 Oct;8(1):e001365. doi: 10.1136/bmjdrc-2020-001365. BMJ Open Diabetes Res Care. 2020. PMID: 33023896 Free PMC article.
Intensive insulin therapy in patients with type 2 diabetes.
DeVries JH, Siegelaar S, Holleman F, Hoekstra JB. DeVries JH, et al. Lancet. 2008 Aug 30;372(9640):717; author reply 717-8. doi: 10.1016/S0140-6736(08)61302-1. Lancet. 2008. PMID: 18761219 No abstract available.
Glucose variability; does it matter?
Siegelaar SE, Holleman F, Hoekstra JB, DeVries JH. Siegelaar SE, et al. Among authors: devries jh. Endocr Rev. 2010 Apr;31(2):171-82. doi: 10.1210/er.2009-0021. Epub 2009 Dec 4. Endocr Rev. 2010. PMID: 19966012 Review.
A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs.
Swinnen SG, Dain MP, Aronson R, Davies M, Gerstein HC, Pfeiffer AF, Snoek FJ, Devries JH, Hoekstra JB, Holleman F. Swinnen SG, et al. Among authors: devries jh. Diabetes Care. 2010 Jun;33(6):1176-8. doi: 10.2337/dc09-2294. Epub 2010 Mar 3. Diabetes Care. 2010. PMID: 20200301 Free PMC article. Clinical Trial.
276 results